This announcement is some further validation of BIT 225. Hopefully this will help attract some funding.
Funding is still a key issue here given BIT's cash on hand.
I thought Biotron were going to do further trials outside the U.S to present to the FDA?
Good to see they have submitted a proposal to the FDA this current quarter as previously announced as BIT isn't known to be punctual.
GLTAH
Ann: BIT225 Effectiveness Against COVID-19 in Animals, page-47
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |